Robert Shapiro, MD
Cardiovascular Disease · Falls Church, VANPI 1740270909
Payments from drug & device makers
Across 21 payments — averaging $90.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$779
- Intuitive Surgical$449
- Abiomed$318
- Cardiovascular Systems Inc.$117
- Boston Scientific$67
- E.r. Squibb & Sons, L.L.C.$33
- plus $129 from 7 others
What the payments were for
- Travel & lodging$1,22865%
- Food & beverage$66535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 3 | $779 |
| Intuitive Surgical | 2 | $449 |
| Abiomed | 3 | $318 |
| Cardiovascular Systems Inc. | 1 | $117 |
| Boston Scientific | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Edwards Lifesciences | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| Blue Earth Diagnostics | 1 | $18 |
| Coloplast | 1 | $16 |
| Atricure, Inc. | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,892 in reported general payments places this provider in the 50th percentile of 548 cardiovascular disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 86 | $120,183 |
| EntrestoSacubitril/Valsartan | 18 | $35,847 |
| Repatha SureclickEvolocumab | 34 | $23,575 |
| Praluent PenAlirocumab | 14 | $11,343 |
| Metoprolol Succinate | 118 | $1,856 |
| Atorvastatin Calcium | 112 | $1,691 |
| Ezetimibe | 34 | $1,461 |
| Rosuvastatin Calcium | 97 | $1,414 |
| ClopidogrelClopidogrel Bisulfate | 57 | $761 |
| Amlodipine Besylate | 91 | $522 |
| Chlorthalidone | 34 | $507 |
| Furosemide | 39 | $461 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $374 |
| Lisinopril | 44 | $313 |
| Potassium Chloride | 21 | $292 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Falls Church
- Tariq HaddadFalls Church$8M
- Henry TranFalls Church$1.6M
- Behnam TehraniFalls Church$514K
- Mitchell PsotkaFalls Church$246K
- Shashank SinhaFalls Church$235K
- Alexander TruesdellFalls Church$176K
- Christopher OconnorFalls Church$161K
- Joseph KreppFalls Church$157K
- David LimCharlottesville$6M
- Hamid TaheriManassas$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.